In this week's video, Dr. Brian Durie discusses selinexor, a novel, orally administered drug that is currently ongoing clinical trials.

Bottom Line:

Selinexor is a promising new type of drug that can make a difference for myeloma patients.

Previous Post
Can the ASCO “Value Framework” work for myeloma patients?
Next Post
Precision Medicine: Is It a Must, a Bust—or Something in Between?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.